↓ Skip to main content

Small-scale high-throughput sequencing–based identification of new therapeutic tools in cystic fibrosis

Overview of attention for article published in Genetics in Medicine, January 2015

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Readers on

mendeley
37 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Small-scale high-throughput sequencing–based identification of new therapeutic tools in cystic fibrosis
Published in
Genetics in Medicine, January 2015
DOI 10.1038/gim.2014.194
Pubmed ID
Authors
Abstract

Purpose:Although 97-99% of CFTR mutations have been identified, great efforts must be made to detect yet-unidentified mutations.Methods:We developed a small-scale next-generation sequencing approach for reliably and quickly scanning the entire gene, including noncoding regions, to identify new mutations. We applied this approach to 18 samples from patients suffering from cystic fibrosis (CF) in whom only one mutation had hitherto been identified.Results:Using an in-house bioinformatics pipeline, we could rapidly identify a second disease-causing CFTR mutation for 16 of 18 samples. Of them, c.1680-883A>G was found in three unrelated CF patients. Analysis of minigenes and patients' transcripts showed that this mutation results in aberrantly spliced transcripts because of the inclusion of a pseudoexon. It is located only three base pairs from the c.1680-886A>G mutation (1811+1.6kbA>G), the fourth most frequent mutation in southwestern Europe. We next tested the effect of antisense oligonucleotides targeting splice sites on these two mutations on pseudoexon skipping. Oligonucleotide transfection resulted in the restoration of the full-length, in-frame CFTR transcript, demonstrating the effect of antisense oligonucleotide-induced pseudoexon skipping in CF.Conclusion:Our data confirm the importance of analyzing noncoding regions to find unidentified mutations, which is essential to designing targeted therapeutic approaches.Genet Med advance online publication 08 January 2015Genetics in Medicine (2014); doi:10.1038/gim.2014.194.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Argentina 1 3%
Unknown 36 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 9 24%
Student > Master 5 14%
Other 4 11%
Student > Doctoral Student 2 5%
Student > Ph. D. Student 2 5%
Other 3 8%
Unknown 12 32%
Readers by discipline
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 12 32%
Agricultural and Biological Sciences 8 22%
Computer Science 2 5%
Medicine and Dentistry 2 5%
Engineering 2 5%
Other 1 3%
Unknown 10 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2026.
All research outputs
#9,675,159
of 30,052,655 outputs
Outputs from Genetics in Medicine
#2,149
of 3,263 outputs
Outputs of similar age
#109,124
of 374,976 outputs
Outputs of similar age from Genetics in Medicine
#29
of 40 outputs
Altmetric has tracked 30,052,655 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 3,263 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.0. This one is in the 33rd percentile – i.e., 33% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,976 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 40 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.